These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2468849)

  • 21. Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle.
    Werner G; Klaus W; Kojda G; Fricke U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):337-44. PubMed ID: 1961259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil as an apparent competitive antagonist of the serotonin receptor of rabbit isolated aorta.
    Auguet M; Delaflotte S; Clostre F; DeFeudis FV
    Gen Pharmacol; 1986; 17(2):133-5. PubMed ID: 3699438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of flunarizine on electrical and mechanical responses of smooth muscle cells in basilar and ear arteries of the rabbit.
    Nagao T; Suzuki H; Kuriyama H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):431-8. PubMed ID: 3774021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of the effect of flunarizine on rabbit isolated vascular muscle.
    Wadsworth RM; Moss JP
    Eur J Pharmacol; 1982 Nov; 85(2):207-9. PubMed ID: 7151868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of calcium antagonists and Bay K 8644 on contractile responses to exogenous noradrenaline and adrenergic nerve stimulation in the rabbit ear artery.
    Skärby TV; Högestätt ED
    Br J Pharmacol; 1990 Dec; 101(4):961-7. PubMed ID: 1707708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein.
    Marriott JF
    Br J Pharmacol; 1988 Sep; 95(1):145-54. PubMed ID: 3219471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
    Miller WC; Moore JB
    Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular effects of LAS 30538, a new vascular selective Ca(2+)-channel blocker.
    Cardelús I; Bou J; Llenas J; Berga P; Gristwood RW
    J Pharm Pharmacol; 1992 Oct; 44(10):830-5. PubMed ID: 1360509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Ca2+ entry blockers on kainate-induced changes in extracellular amino acids and Ca2+ in vivo.
    Lazarewicz JW; Lehmann A; Hamberger A
    J Neurosci Res; 1987; 18(2):341-4. PubMed ID: 3155423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of UK-84149 on voltage-activated calcium currents of single smooth muscle cells from guinea-pig and rabbit jejunum and rabbit coronary artery.
    Zhang H; Bolton TB
    Br J Pharmacol; 1995 Apr; 114(8):1657-65. PubMed ID: 7599936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
    Chen M; Xiao CY; Hashizume H; Abiko Y
    Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
    Montiel C; Herrero CJ; García-Palomero E; Renart J; García AG; Lomax RB
    Eur J Pharmacol; 1997 Aug; 332(2):183-93. PubMed ID: 9286620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusion.
    Nayler WG; Sturrock WJ
    J Cardiovasc Pharmacol; 1985; 7(3):581-7. PubMed ID: 2410693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
    Santos DL; Lopes MC; Carvalho CM
    Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of calcium antagonists on mean circulatory filling pressure in the conscious rat.
    Waite RP; Pang CC; Walker MJ
    J Cardiovasc Pharmacol; 1988; 12(5):499-504. PubMed ID: 2468047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB
    Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Ca2+ channel antagonists in guinea-pig normal and skinned gall bladder.
    Cejalvo D; Calvo MA; Lloris JM; Cortijo J; Morcillo EJ
    Eur J Pharmacol; 1993 Mar; 234(1):23-8. PubMed ID: 8472758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presynaptic alpha 2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices.
    Galzin AM; Langer SZ
    Br J Pharmacol; 1983 Mar; 78(3):571-7. PubMed ID: 6132643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dihydropyridine calcium antagonists on rabbit renal Na,K-ATPase activity in vitro.
    Kloke HJ; Swarts HG; Sluiter HE; Huysmans FT; De Pont JJ
    Eur J Pharmacol; 1988 Feb; 147(1):119-23. PubMed ID: 2836215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.